Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
暂无分享,去创建一个
A R Dunn | C. Cheers | A. Dunn | K. Fowler | E. Stanley | G. Lieschke | D. Metcalf | G J Lieschke | D Grail | G Hodgson | D Metcalf | E Stanley | C Cheers | K J Fowler | S Basu | Y F Zhan | Y. Zhan | G. Hodgson | E. Stanley | S. Basu | D. Grail | Yi F. Zhan | Sunanda Basu
[1] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[2] J. W. Conlan,et al. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody , 1994, The Journal of experimental medicine.
[3] M. Steinmetz,et al. IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.
[4] M. Capecchi,et al. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.
[5] D. Metcalf. Hematopoietic regulators: redundancy or subtlety? , 1993, Blood.
[6] K. Zsebo,et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Demetri,et al. Granulocyte colony-stimulating factor and its receptor. , 1991, Blood.
[8] A. Dunn,et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] Y. Ueyama,et al. Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). , 1987, Biochemical and biophysical research communications.
[10] T. Kumakawa,et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. , 1990, Blood.
[11] S. Nagata,et al. The chromosomal gene structure for murine granulocyte colony-stimulating factor. , 1987, European journal of biochemistry.
[12] D. Metcalf. Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. Dexter,et al. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. , 1991, Blood.
[14] A. Mauer,et al. Defective myelopoiesis in congenital neutropenia. , 1970, The New England journal of medicine.
[15] S. Nagata,et al. Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Nishikawa,et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.
[17] D. Metcalf. The hemopoietic colony stimulating factors , 1984 .
[18] S. Asano,et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. , 1989, Blood.
[19] C. Cheers,et al. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis , 1978, Infection and immunity.
[20] J. Villeval,et al. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. , 1988, Blood.
[21] A. Dunn,et al. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. , 1994, Blood.
[22] G. Dranoff,et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.
[23] George Morstyn,et al. Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor , 1989 .
[24] E. Nice,et al. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation , 1993, Cell.
[25] T. Gonda,et al. Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. , 1989, The Journal of clinical investigation.
[26] J. Gabrilove,et al. Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis. , 1987, Haematology and blood transfusion.
[27] K. Welte,et al. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. , 1991, Blood.
[28] J. F. Brown,et al. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. , 1994, Journal of immunology.
[29] D. Dale,et al. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. , 1991, The Journal of clinical investigation.
[30] W. Wiktor-Jedrzejczak. In vivo role of macrophage growth factors as delineated using CSF-1 deficient op/op mouse. , 1993, Leukemia.
[31] R. North,et al. THE RELATIVE IMPORTANCE OF BLOOD MONOCYTES AND FIXED MACROPHAGES TO THE EXPRESSION OF CELL-MEDIATED IMMUNITY TO INFECTION , 1970, The Journal of experimental medicine.
[32] W. Wiktor-Jedrzejczak,et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] T. Dexter,et al. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. , 1990, Experimental hematology.